Literature DB >> 22286309

The interplay of iron(II) spin transition and polymorphism.

Ivan Šalitroš1, Olaf Fuhr, Andreas Eichhöfer, Robert Kruk, Ján Pavlik, Lubor Dlháň, Roman Boča, Mario Ruben.   

Abstract

The mononuclear compound (1) [Fe(II)(L)(2)](BF(4))(2) (L = 4-ethynyl-2,6-bis(pyrazol-1-yl)pyridine) was prepared and structurally as well as magnetically characterised. The crystallisation revealed the formation of two polymorphs--the orthorhombic 1A and the tetragonal form 1B. A third, intermediate phase 1C was found exhibiting a different orthorhombic space group. Reversibility of the phase transition between 1A and 1C was studied by variable-temperature single-crystal and powder X-ray diffraction studies, while an irreversible phase transition was observed for the transition of 1B→1C. The magnetic studies show that the 1A↔1C transition is accompanied by a very abrupt spin transition (ST) with 8 K hysteresis width (T(1/2)(↓) = 337 K, T(1/2)(↑) = 345 K). The ST was confirmed by Mössbauer spectroscopy as well as by DSC studies. In contrast, the 1B polymorph remained low-spin up to 420 K. In conclusion, a full cycle of intertwined phase- and spin-conversions of three polymorphs could be proven following the general scheme 1B→1C↔1A.

Entities:  

Year:  2012        PMID: 22286309     DOI: 10.1039/c2dt11906d

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Solvent-Induced Polymorphism of Iron(II) Spin Crossover Complexes.

Authors:  Ivan Šalitroš; Olaf Fuhr; Mario Ruben
Journal:  Materials (Basel)       Date:  2016-07-19       Impact factor: 3.623

2.  Structural Insights into Hysteretic Spin-Crossover in a Set of Iron(II)-2,6-bis(1H-Pyrazol-1-yl)Pyridine) Complexes.

Authors:  Nithin Suryadevara; Asato Mizuno; Lea Spieker; Soma Salamon; Stephan Sleziona; André Maas; Erik Pollmann; Benoît Heinrich; Marika Schleberger; Heiko Wende; Senthil Kumar Kuppusamy; Mario Ruben
Journal:  Chemistry       Date:  2022-01-19       Impact factor: 5.020

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.